Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Ueda

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Scientific Reports|March 20, 2025
Predicting coronavirus disease 2019 severity using explainable artificial intelligence techniquesTakuya Ozawa, Shotaro Chubachi, Ho Namkoong, et al.
Respiratory Research|November 15, 2022
Impact of upper and lower respiratory symptoms on COVID-19 outcomes: a multicenter retrospective cohort studyKensuke Nakagawara, Shotaro Chubachi, Ho Namkoong, et al.
Open Forum Infectious Diseases|July 13, 2023
Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task ForceHiromu Tanaka, Shotaro Chubachi, Ho Namkoong, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 22, 2023
Diagnostic significance of secondary bacteremia in patients with COVID-19Kensuke Nakagawara, Hirofumi Kamata, Shotaro Chubachi, et al.
BMC Pulmonary Medicine|April 26, 2023
Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort studyKensuke Nakagawara, Hirofumi Kamata, Shotaro Chubachi, et al.
Nature Communications|August 22, 2022
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task ForceQingbo S Wang, Ryuya Edahiro, Ho Namkoong, et al.
Nature|August 8, 2022
DOCK2 is involved in the host genetics and biology of severe COVID-19Ho Namkoong, Ryuya Edahiro, Tomomi Takano, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Scientific Reports|March 20, 2025
Predicting coronavirus disease 2019 severity using explainable artificial intelligence techniquesTakuya Ozawa, Shotaro Chubachi, Ho Namkoong, et al.
Respiratory Research|November 15, 2022
Impact of upper and lower respiratory symptoms on COVID-19 outcomes: a multicenter retrospective cohort studyKensuke Nakagawara, Shotaro Chubachi, Ho Namkoong, et al.
Open Forum Infectious Diseases|July 13, 2023
Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task ForceHiromu Tanaka, Shotaro Chubachi, Ho Namkoong, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 22, 2023
Diagnostic significance of secondary bacteremia in patients with COVID-19Kensuke Nakagawara, Hirofumi Kamata, Shotaro Chubachi, et al.
BMC Pulmonary Medicine|April 26, 2023
Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort studyKensuke Nakagawara, Hirofumi Kamata, Shotaro Chubachi, et al.
Nature Communications|August 22, 2022
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task ForceQingbo S Wang, Ryuya Edahiro, Ho Namkoong, et al.
Nature|August 8, 2022
DOCK2 is involved in the host genetics and biology of severe COVID-19Ho Namkoong, Ryuya Edahiro, Tomomi Takano, et al.
Pageof 15